Alzheimer’s Los Angeles supports Proposition 38, The Immunology Medical Research & Cures Initiative, because it funds critical immunology research in California. Immunotherapies help treat symptoms and slow progression of Alzheimer’s disease, and they are one of the most promising areas of Alzheimer’s disease research. As the number of Californians living with Alzheimer’s and other dementias grows, immunotherapies offer hope for a world free of Alzheimer’s disease. Investment in California’s biomedical research will accelerate discoveries for the thousands of families impacted by dementia.

Alzheimer’s Los Angeles is a non-profit organization dedicated to improving the lives of local families affected by Alzheimer’s and other dementias, delivering effective programs and services, providing compassionate support, and advocating for quality care and a cure. Our work is focused on bringing resources and supports to underserved and underrepresented communities who often have limited access to medical care. Communities of color are disproportionately impacted by Alzheimer’s disease. Compared to whites, Blacks are twice as likely and Latinos are one and a half times as likely to have Alzheimer’s disease, yet they often lack access to clinical trials and their subsequent findings. Participation of diverse communities in immunology research for Alzheimer’s disease will ensure that cutting-edge therapies are safe and effective across all genetic backgrounds.